Abstract:Objective: To study the ameliorative effect of intravenous thrombolysis with alteplase combined with safflower extract on acute cerebral infarction (ACI) and the potential mechanism. Methods: Among 30 SD rats, 6 were randomly selected as sham-operated group, and the rest were constructed as acute cerebral infarction model. After successful construction of the model, the modeled rats were randomly divided into model group, alteplase group (tail vein injection of alteplase 5 mg/kg), safflower extract group (tail vein intravenous 4 g/kg), and alteplase combined with safflower extract group, 6 rats in each group. Rats in each administration group were given the corresponding interventions, and rats in the sham-operated and model groups were injected with an equal volume of sterile 0.9% sodium chloride solution for 7 days. The neurological deficits were scored by Zea Longa; the infarct area was evaluated by TTC staining; histopathological changes were observed by HE staining; Evans blue content was determined; the apoptosis was detected by TUNEL method; TLR4, NF-κB p65, NLRP3 mRNA expression in brain tissue was detected by qRT-PCR; Western blotting analysis of protein expression of MMP-2, MMP-9, Bax, Bcl-2, TLR4, NF-κB p65, p-NF-κB p65, NLRP3, caspase1, pro-IL-1β in brain tissues. Results: Compared with the sham-operated group, the model group had significantly higher Zea Longa score, significantly increased infarct area, and EB content, apoptosis rate, MMP-2, MMP-9, Bax, TLR4, NF-κB p65, NLRP3, p-NF-κB p65, caspase1, pro-IL-1β protein expression and TLR4, NF-κB p65, NLRP3 mRNA expression were significantly higher and Bcl-2 protein expression was significantly lower (P<0.05). Compared with the model group, alteplase combined with safflower extract group could significantly reduce Zea Longa score and infarct area, EB content, apoptosis rate, MMP-2, MMP-9, Bax, TLR4, NF-κB p65, NLRP3, p-NF-κB p65, caspase1, pro-IL-1β protein expression and TLR4, NF-κB p65, NLRP3 mRNA expression was significantly decreased and Bcl-2 protein expression was significantly increased (P<0.05). Conclusion: Alteplase intravenous thrombolysis combined with safflower extract has a protective effect in rats with acute cerebral infarction, and it is a potential therapy to improve the impaired neurological function in acute cerebral infarction by inhibiting TLR4-NLRP3 signaling pathway and reducing apoptosis.
刘明亮, 杨森林, 马超. 阿替普酶联合红花提取物调节TLR4-NLRP3信号通路对大鼠急性脑梗塞的影响[J]. 河北医学, 2023, 29(9): 1426-1431.
LIU Mingliang, YANG Senlin, MA Chao. Effects of Alteplase Combined with Safflower Extract on ACI in Rats through the Regulation of TLR4-NLRP3 Signaling Pathway. HeBei Med, 2023, 29(9): 1426-1431.
[1] Sun Z,Xu Q,Gao G,et al.Clinical observation in edaravone treatment for acute cerebral infarction[J].Niger Clin Pract,2019,22(10):1324-1327. [2] Wu T,Li P,Sun D.Assessing the clinical efficacy of recombinant tissue plasminogen activator on acute cerebral infarction[J].Nanosci Nanotechnol,2020,20(12):7781-7786. [3] 于海燕,王东玉,闵连秋.阿替普酶对脑梗死大鼠的疗效观察及对血清中GAP-43、NGF、MDA水平的影响[J].河北医药,2020,42(4):503- 507. [4] Wu W,Qiu C,Feng X,et al.Protective effect of paeoniflorin on acute cerebral infarction in rats[J].Curr Pharm Biotechnol,2020,21(8):702-709. [5] 牛恒立,伏计能,马云海.红花提取物对大鼠心脏缺血再灌注的保护作用及机制研究[J].中国现代应用药学,2019,36(12):1492-1497. [6] 杨波.原花青素通过抑制TLR4-NLRP3通路对脑缺血再灌注损伤的保护作用研究[D].南方医科大学,2022. [7] Wang D,Peng X,Yang A,et al.Edaravone promotes nerve function recovery after acute cerebral infarction in rats via targeting Keap1-Nrf2/ARE[J].Panminerva Med,2021,63(3):384-385. [8] Liu YP,Ju ML,Yu FQ.Clinical significance of FSTL 1,Bax,Bcl-2 in acute cerebral infarction and its relationship with hemorrhagic transformation[J].Eur Rev Med Pharmacol Sci,2020,24(16):8447-8457. [9] Adams JM,Cory S.The BCL-2 arbiters of apoptosis and their growing role as cancer targets[J].Cell Death Differ,2018,25(1):27-36. [10] Nalamolu KR,Challa SR,Fornal CA,et al.Attenuation of the induction of TLRs 2 and 4 mitigates inflammation and promotes neurological recovery after focal cerebral ischemia[J].Transl Stroke Res,2021,12(5):923-936. [11] Voet S,Srinivasan S,Lamkanfi M,et al.Inflammasomes in neuroinflammatory and neurodegenerative diseases[J].EMBO Mol Med,2019,11(6):10248. [12] 杨才弟,汪正於,曾鼎华,等.NLRP3炎症小体参与脑缺血再灌注损伤的研究进展[J].中国免疫学杂志,2022,38(13):1657-1660. [13] 郝广志,邹正,陈立刚,等.TLR4-NLRP3介导蛛网膜下腔出血早期大鼠神经细胞焦亡[J].神经解剖学杂志,2022,38(1):74-78. [14] 林兰明,宋征宇,胡瑾.金合欢素调节TLR4/NLRP3信号通路对脑缺血再灌注损伤模型大鼠的保护作用[J].中国中药杂志,2023,(7):1-9.